Risks

Negative interest coverage and very high debt-to-equity versus peers increase refinancing sensitivity, while stronger balance sheets at larger healthcare distributors reduce this relative pressure.

A 375-day cash conversion cycle driven by 428 days of inventory ties up capital, leaving ESTA more exposed to working-capital swings than faster-turning peers.

Days sales outstanding above 112 days suggest slower collections, which can constrain liquidity and amplify margin volatility versus peers with tighter receivables discipline.

Although current and quick ratios are solid, the negative net debt-to-EBITDA profile implies earnings quality is not yet supporting leverage, limiting resilience versus profitable peers.

Opportunities

Strong current and quick ratios provide near-term liquidity flexibility, giving ESTA more room to absorb demand or reimbursement volatility than more levered peers.

Negative net debt-to-EBITDA indicates net cash positioning, which can support inventory availability and working-capital needs better than indebted peers if operating performance stabilizes.

High inventory days can support service levels and product availability, potentially improving fill rates versus leaner peers if demand remains steady.

If collections improve and inventory normalizes, the large working-capital base could release cash faster than peers with less balance-sheet flexibility.

Overall Score

ESTA’s positioning is constrained by weak interest coverage and a long cash conversion cycle versus peers, but strong liquidity and net cash provide some offset.